On the cellular level, we observed an immediate and temporary upregulation in the percentage of late transitional and regulatory B cells at 8 h vs. baseline following AIT launch in VAP that was accompanied by a transient decrease in the percentage of allergen-specific CD4+ T cells at 24 h. The gene discussed is CD4; the disease is ventilator-associated pneumonia.